Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France

An indirect in-house immunofluorescent assay was developed in order to assess the serological status of COVID-19 patients in Marseille, France. Performance of IFA was compared to a commercial ELISA IgG kit. We tested 888 RT-qPCR-confirmed COVID-19 patients (1302 serum samples) and 350 controls inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Edouard, S., Colson, P., Melenotte, C., Di Pinto, F., Thomas, L., La Scola, B., Million, M., Tissot-Dupont, H., Gautret, P., Stein, A., Brouqui, P., Parola, P., Lagier, J.-C., Raoult, D., Drancourt, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657073/
https://www.ncbi.nlm.nih.gov/pubmed/33179133
http://dx.doi.org/10.1007/s10096-020-04104-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657073/
https://www.ncbi.nlm.nih.gov/pubmed/33179133
http://dx.doi.org/10.1007/s10096-020-04104-2

Ejemplares similares